| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.091 | 0.07 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.07 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.096 | 0.07 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.08 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.088 | 0.08 |